Ticker: LXEO

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) - What's happening inside the company (quick, factual summary) Snapshot / liquidity & capital: * Cash and cash equivalents (June 30, 2025): $35.48 million (reported in thousands). * Investments in U.S. Treasury securities (current + non-current): $117.026 m...

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is a clinical-stage genetic medicine company focused on hereditary and acquired diseases. The company aims to develop gene therapy-based treatments using adeno-associated viruses (AAVs). As of March 31, 2025, Lexeo reported substantial financial metrics tha...